Anthos Therapeutics
Cambridge
About Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases. The company was founded by a world-class executive team with extensive experience in the development and commercialization of CVM disease therapies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $250.0M
- Funding stage: M&A
- Last round: Series A (Feb 2019)
- Website: anthostherapeutics.com
- Phone: 617-430-6940
Industries & Categories
Biopharma, Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/anthos-therapeutics-47894 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.